Latest News
VirTrial Acquires SnapMD to Improve Patient Engagement Platform
Friday 13 December 2019

13 December 2019 - Telemedicine company VirTrial has acquired telemedicine tools provider SnapMD, an industry-provider of telemedicine tools and services that improve patient engagement.

VirTrial is a portfolio company of private investment firm Kinderhook Industries, LLC.

Terms of the transaction were not disclosed.

The acquisition bolsters VirTrial's capabilities with access to SnapMD's telemedicine platform and technical expertise. The relationship enables integration of additional features and capabilities into VirTrial's Virtual Care Management platform to further establish VirTrial as the dominant global decentralised clinical trial solution in the market.

The acquisition supports VirTrial's goal of making hybrid decentralised clinical trials seamless for sponsors, sites, and patients.

VirTrial provides a stable, long-standing virtual care management platform to transform the clinical trial industry. The platform combines video, text, and email allowing pharmaceutical companies and CROs to create patient centric decentralised clinical trials by replacing some study visits with virtual visits.

SnapMD offers enterprise-level Virtual Care Management telehealth platform.

The full-stack software solution enables healthcare providers to engage their patients via a comprehensive, secure, HIPAA/HITECH/COPPA compliant, cloud-based telemedicine platform with back-end systems to manage the digital health care continuum.
Date Published: 13/12/2019
Target: SnapMD
Country: USA
Sector: Healthcare
Type: LBO
Status: Closed
Buyer: VirTrial
Terms of the deal were not disclosed